Screener
GeneDx Holdings WGS EBITDA
Discontinued — last reported Q1 '26
EBITDA at other companies
Other financials
Where this comes from
Calculated from GeneDx Holdings’s reported figures.
The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001818331-26-000041
FAQ
- What is GeneDx Holdings's EBITDA?
- GeneDx Holdings (WGS) reported EBITDA of -$50.66M in Q1 2026.
- How has GeneDx Holdings's EBITDA changed year-over-year?
- GeneDx Holdings's EBITDA decreased by 4595.3% year-over-year, from $1.13M to -$50.66M.
- What is the long-term trend for GeneDx Holdings's EBITDA?
- Over 3 years (2021 to 2025), GeneDx Holdings's EBITDA has grown at a -59.7% compound annual growth rate (CAGR), from -$185.36M to $12.15M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about GeneDx Holdings's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude